Changes in the CTU Cancer Group

23 Jun 2014

In March 2010 Max Parmar, currently Head of the Cancer Group, will take up his new role as Director of the MRC Clinical Trials Unit. This will, of course, bring a number of new responsibilities both for him and the Cancer Group senior staff.

While Max plans to continue his current trial-specific role for several of our cancer trials, and in the cancer community more generally, the Cancer Group as a whole will be managed by the Cancer Leads: Rick Kaplan, Ruth Langley, Sally Stenning, Ann Marie Swart and Matthew Sydes. Specific roles and responsibilities will be developed further as Max considers the organisational structure of the unit overall. In the meantime, our external collaborators who have developed links with senior Cancer Group staff members should continue to use their existing contacts. The Cancer leads as a group can be contacted at CancerLeads@ctu.mrc.ac.uk.